Financial Result

Revenue Growth 20pctPat Growth 25pctRelated Party TransactionsNegative Operating CashflowResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.5%Reaction day

₹0.68

prior close

₹0.71

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.3%-2.8% vs market

Retailing peers, median of 54sector · industry level+1.0%-2.4% vs sector

On the reaction day the stock moved 2.8 pts less than Nifty Microcap 250 and 2.4 pts less than its Retailing peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.4

10m

-1.4

15m

-2.8

30m

-2.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.5+1.3-2.8+1.0-2.4

Next day

+0.0+0.9-0.9+0.3-0.3

-1.5+0.8-2.2+0.1-1.6

-2.9+0.6-3.5-0.2-2.8

-5.9-0.0-5.9-0.5-5.4

-23.5-0.5-23.0-1.2-22.4

-17.6-2.1-15.5-2.2-15.4

15d

-8.8-3.5-5.3-4.3-4.5

+7.4-2.3+9.6-4.5+11.8

+22.1-10.4+32.4-15.0+37.1

+17.6-6.1+23.8-16.7+34.3

UpDownMarket · Nifty Microcap 250Sector · Retailing peers, median of 54Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Sattva Sukun Lifecare (formerly Mayukh Dealtrade) reported strong revenue growth with standalone H1 FY26 net sales rising to Rs. 317.53 lakhs (vs Rs. 225.60 lakhs in H1 FY25, up ~41%) and standalone H1 PAT growing to Rs. 125.53 lakhs (vs Rs. 95.57 lakhs, up ~31%). Consolidated H1 FY26 net sales surged to Rs. 1,805.88 lakhs and consolidated PAT to Rs. 131.55 lakhs, driven by newly consolidated subsidiaries. The company completed a Rights Issue of Rs. 19.16 crores during the quarter, allotting 19.16 crore equity shares of Re. 1 each. No deviation in use of rights issue proceeds was reported and there are no loan defaults. However, operating cash flow was deeply negative at Rs. -229.35 lakhs (standalone) and Rs. -1,317.79 lakhs (consolidated), with profits not converting to cash due to working capital expansion.

Likely market impact

Top-line and profit growth are strong on the surface, but the sharp divergence between reported profits and negative operating cash flows is a red flag for shareholders, suggesting working capital is consuming cash. Equity dilution from the bonus issue and large rights issue has compressed EPS significantly, though the fund raise supports the company's expansion plans.